Determination of the in vivo effects of cladribine alone and its combination with cyclophosphamide or cyclophosphamide and mitoxantrone on Bax and Bcl-2 protein expression in B-CLL cells

Oncology Reports

Volumn 11, Issue 3, 2004, Pages 699-705

  Kobylinska, Agnieszka ^a   Blonski, Jerzy Z ^b   Hanausek, Malgorzata ^c   Walaszek, Zbigniew ^c   Robak, Tadeusz ^b   Kilianska, Zofia M ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

B cell chronic lymphocytic leukemia (B CLL); Bax; Bax Bcl 2 ratio; Bcl 2; DNA fragmentation; Drug induced apoptosis; Western blot

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BAX PROTEIN, HUMAN; CLADRIBINE; CYCLOPHOSPHAMIDE; DNA FRAGMENT; MITOXANTRONE; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2;

AGED; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CELL FRACTIONATION; CELL NUCLEUS; CLINICAL TRIAL; DENSITOMETRY; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL NUCLEUS; CLADRIBINE; CYCLOPHOSPHAMIDE; DENSITOMETRY; DNA FRAGMENTATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IMMUNOBLOTTING; LEUKEMIA, B-CELL; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MITOXANTRONE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUBCELLULAR FRACTIONS;

EID: 4644229322     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.3.699     Document Type: Article

References (56)

1. Blankenberg FG, Tait JF and Strauss HW: Apoptotic cell death: its implication for imaging in the next millennium. Eur J Nucl Med 27: 359-367, 2000. (Pubitemid 30167709)
2. Daniel PT: Dissecting the pathways to death. Leukemia 14: 2035-2044, 2000.
3. Roshal M, Zhu Y and Planelles V: Apoptosis on AIDS. Apoptosis 6: 103-116, 2001.
4. Lowe SM and Lin AW: Apoptosis in cancer. Carcinogenesis 21: 485-495, 2000.
5. Thomas A, Pepper C, Hoy T and Bentley P: Bcl-2 and Bax expression and chlorambucil-induced apoptosis in the T-cells and leukemic B-cells of untreated B-cell chronic lymphocytic leukemia patients. Leuk Res 24: 813-821, 2000.
6. McConkey DJ, Aquiilar-Sentelises M, Hartzel P, Eriksson J, Mellstedt H, Orrenius S and Jondal M: Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. J Immunol 146: 1072-1076, 1991.
7. Bellosillo B, Pique M, Barragan M, et al: Aspirin and salicytate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92: 1406-1414, 1998. (Pubitemid 28369055)
8. Chow KU, Rummel MJ, Weidmann E, et al: Induction of apoptosis by 2-chloro-2′-deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone. Leuk Lymph 36: 559-567, 2000. (Pubitemid 30103181)
9. Gandhi V and Plunkett W: Combination strategies for purine nucleoside analogs. In: Chronic Lymphoid Leukemias. Cheson BD (ed). Marcel Dekker, Inc., Basel, New York, pp195-208, 2001.
10. Wieder T, Prokop A, Bagci B, et al: Piceatanol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary leukemic lymphoblasts. Leukemia 15: 1735-1742, 2001. (Pubitemid 33061841)
11. Wieder T, Essmann F, Prokop A, et al: Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD 95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Blood 97: 1378-1387, 2001. (Pubitemid 32183762)
12. Hoffman M, Xu JC, Lesser M and Rai K: Cytotoxity of 2- chlorodeoxyadenosine (cladribine, 2-CdA) in combination with other chemotherapy drugs against two lymphoma cell lines. Leuk Lymph 33: 14-15, 1999.
13. Bellosillo B, Villamor N, Colomer D, Pons G, Montserrat E and Gil J: In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia. Blood 94: 2836-2843, 1999. (Pubitemid 29477312)
14. Gale RP, Caligaris-Carpio F, Dighiero G, Keating M, Montserrat E and Rai K: Recent progress in chronic lymphocytic leukemia. International Workshop on Chronic Lymphocytic Leukemia. Leukemia 8: 1610-1614, 1994.
15. Reed JC: Molecular biology of chronic lymphocytic leukemia: implications for therapy. Semin Hematol 35: 3-13, 1998.
16. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
17. Corry S and Adams JA: The Bcl-2 family: regulators of the cellular life - or - death switch. Nat Rev Cancer 2: 647-656, 2002.
18. Baliga BC and Kumar S: Role of Bcl-2 family of proteins in malignancy. Hematol Oncol 20: 63-74, 2002. (Pubitemid 34654300)
19. Mirkes PE: To die or not to die, the role of apoptosis in normal and abnormal mammalian development. Teratology 65: 228-239, 2002.
20. Cepero E, Johnson BW and Boise LH: Cloning and analysis of Bcl-2 family genes. Cell Biol 66: 24-47, 2001.
21. Tsujimoto Y, Crossman J, Jaffe E and Croce CM: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443, 1985. (Pubitemid 15041322)
22. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W and Reed JC: Investigation of the subcelluler distribution of the Bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial mambranes. Cancer Res 53: 4701-4714, 1993. (Pubitemid 23304404)
23. Nakano A, Morikawa S and Harada T: Ubiqitous expression of Bcl-2 protein in mitotic nuclei and chromosomes. Acta Histochem Cytochem 31: 475-483, 1998. (Pubitemid 29125999)
24. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
25. Pepper C, Hoy T and Bentley DP: Bcl-2/Bax ratios in chronic lymphocytic leukemia and their correlation with in vitro apoptosis and clinical resistance. Br J Cancer 76: 935-958, 1997.
26. Schmitt CA and Lowe SW: Bcl-2 mediates chemoresistance in matched pairs of primary E(mu)myc lymphomas in vivo. Blood Cells Mol Dis 27: 206-216, 2001. (Pubitemid 32299776)
27. Brady HJ and Gil-Gomez G: Bax: the proapoptotic Bcl-2 family member, Bax. Int J Biochem Cell Biol 30: 647-650, 1998. (Pubitemid 28308493)
28. Eskes R, Desagher S, Antonsson B and Martinou JC: Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 20: 929-935, 2000. (Pubitemid 30044230)
29. Godlewski MM, Motyl MA, Gajkowska B, Wareski P, Koronkiewicz M and Motyl T: Subcellular redistribution of Bax during apoptosis induced by anticancer drugs. Anticancer Drugs 12: 607-617, 2001. (Pubitemid 32762808)
30. Wang ZH, Ding MX, Chew-Cheng SB, Yun JP and Chew EC: Bcl-2 and Bax proteins are nuclear matrix associated proteins. Anticancer Res 19: 5445-5450, 1999.
31. Oltvai Z and Korsmayer S: Bcl-2 heterodimerizes in vivo with conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993. (Pubitemid 23259742)
32. Prokop A, Wieder T, Sturm I, et al: Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontanous caspase-3 processing in vivo. Leukemia 14: 1606-1613, 2000.
33. Beutler E: Drug profiles. Cladribine (2-chlorodeoxyadenosine). Lancet 340: 952-956, 1992.
34. Rai KR: Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia. Semin Oncol (Suppl. 7) 25: 19-22, 1998.
35. Robak T: Cladribine in treatment of chronic lymphocytic leukemia. Leuk Lymph 40: 561-564, 2001.
36. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brieu S and Rai KR: National Cancer Institute - sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87: 4990-4997, 1996. (Pubitemid 26189840)
37. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN and Pasternack BS: Clinical staging of chronic lymphocytic leukemia. Blood 46: 219-234, 1975.
38. Robak T, Blonski JZ, Kasznicki M, et al: Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial. Blood 96: 2723-2729, 2000.
39. Robak T, Blonski JZ, Kasznicki M, et al: Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in B-cell chronic lymphocytic leukemia. Leukemia 15: 1510-1516, 2001. (Pubitemid 32994668)
40. Robak T, Blonski JZ, Kasznicki M, Gora-Tybor J, Dwilewicz-Trojaczek J, Stella-Holowiecka B and Wolowiec D: Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia. Hematol J 3: 244-250, 2002. (Pubitemid 35331384)
41. Böyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21: 77-89, 1968.
42. Fadeel B, Hassan Z, Hellstrom-Lindberg E, Heuter J, Orrenius S and Zhivotovsky B: Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells. Leukemia 13: 719-728, 1999. (Pubitemid 29243623)
43. Blobel G and Potter VR: Nuclei from rat liver: isolation method that combines purity with high yield. Science 154: 1662-1665, 1966.
44. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
45. Towbin H, Staechlin T and Gordon J: Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979. (Pubitemid 9256559)
46. Leary JJ, Brigati JJ and Ward DC: Rapid biotin labelled DNA probes hybrized to DNA or RNA immobilized on nitrocellulose: Bio-blots. Proc Natl Acad Sci USA 80: 4045-4049, 1983.
47. Rolfs A, Schuller I, Finckh U and Weber-Rolfs I: PCR: Clinical Diagnostic and Research. Springer Lab., pp81-84, 1992.
48. Wright DK and Manos MM: Sample preparation from paraffin-embedded tissues. In: PCR Protocols: A Guide to Methods and Applications. Innis MA, Gelfand DH, Sninsky JJ and White TJ (eds). Academic Press, Inc., pp153-158, 1990.
49. Lowry OH, Rosebrough NJ and Farr AL: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
50. Pepper C, Thomas A, Hoy T and Bentley P: Chlorambucil resistance in B-cell chronic lymphocytic leukemia is mediated through failed Bax induction and selection of high Bcl2 expressing subclones. Br J Haematol 104: 581-588, 1999. (Pubitemid 29119285)
51. Reed J: Bcl-2 family proteins: regulators of chemiresistance in cancer. Toxicol Lett 82/83: 155-158, 1995.
52. Robertson LE, Plunkett W, McConnell K, Keating MJ and McDonnel TJ: Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia 10: 456-459, 1996. (Pubitemid 26128784)
53. Wheaton S, Netser J, Guinee D, Rahm M and Perkins S: Bcl-2 and Bax protein in indolent versus aggressive B-cell non-Hodgkin's lymphomas. Hum Pathol 29: 820-825, 1998. (Pubitemid 28375988)
54. Chandra J, Mansson E, Gogvadze V, Kaufmann SH, Albertioni F and Orrenius S: Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release. Blood 99: 655-663, 2002. (Pubitemid 34533105)
55. Genini D, Adachi S, Chao Q, et al: Deoxyadenosine analogs induced programmed cell death in chronic lymphocytic leukemia by damaging the DNA and by directly affecting the mitochondria. Blood 96: 3537-3543, 2000.
56. Marzo I, Perez-Galan P, Giraldo P, Rubio-Felix D, Anel A and Naval J: Cladribine induces apoptosis in human leukaemia cells by caspase-dependent and -independent pathways acting on mitochondria. Biochem J 359: 537-546, 2001. (Pubitemid 33063377)